What is the difference between the generic version of Vigabatrin/vigabatrin and the original drug?

Vigabatrin/vigabatrin is a special anti-epileptic drug used to treat epilepsy, especially refractory epilepsy and infantile spasms. Its original drug was first launched by Sanofi. As the patent period expires, multiple versions of generic drugs have also been launched on the market. These generic drugs are usually consistent in terms of active ingredients, specifications and clinical effects, but may differ in terms of production location, price and excipient composition. Therefore, when choosing to use, it is necessary to comprehensively consider the efficacy guarantee, economy and the formality of drug purchase channels.

In terms of drug ingredients, whether it is the original drug or the generic drug, the main active ingredient is vigabatrin, and the mechanism of action is the same. They both increase GABA levels in the brain through irreversible inhibition ofGABA transaminase, thereby achieving anti-epileptic effects. Therefore, at the efficacy level, quality generic drugs and brand-name drugs usually perform similarly in controlling epileptic seizures. In particular, companies such as Lucius Pharmaceuticals in Laos and Natco in India have reached international GMP standards for their generic drug production, and their products are exported to many countries and regions, ensuring efficacy while reducing medication costs.

In terms of specifications, the Vigabatrin oral solution dispersible tablets currently on the market are mainly packed in 500mg packaging. The original research version available in China is 500mg×30 bags/box. The Hong Kong version and the Turkish version are usually in large packages of 500 mg × 100 bags, which are more cost-effective. Generic drugs produced by Lucius Pharmaceuticals in Laos are also available in 500 mg × 100 bags. The price is slightly lower than other imported versions, making it suitable for patients with limited economic conditions.

The price difference is significant. Taking the 500mg specification as an example, the price of 30 bags of the original drug is usually more than 1,000 yuan before medical insurance reimbursement, while the price of 100 bags of the Hong Kong version or the Turkish version is also around 1,000 yuan, but the cost per bag is lower. Due to the flexible manufacturing cost and pricing strategy of Lao generic drugs, the price of each box of 500 mg × 100 bags is approximately 900 yuan (which may fluctuate due to exchange rate effects), making it an alternative choice for many patients with limited economic conditions.

Reference materials:https://www.sabril.net/